Our data as summarized here provide a novel mechanism that links nutrient surplus to SIRT1 repression and present PIAS4 as a potential druggable target for NASH intervention (Figure 6). The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatohepatitis.